Bharat Biotech

New Delhi: India's first intranasal Covid vaccine by Bharat Biotech on Tuesday got the approval from the Drug Controller General of India for 18+ age group for restricted use in emergency situation. Announcing the achievements, Union…
Read More...

Hyderabad: Vaccine-maker Bharat Biotech announced on Monday that its intranasal vaccine for Covid-19 has been proven to be safe, well-tolerated, and immunogenic in subjects in controlled clinical trials. The Hyderabad-based company…
Read More...

Hyderabad: Vaccine maker Bharat Biotech on Wednesday announced partnership with Spanish biopharmaceutical company Biofabri to develop, manufacture and market a new tuberculosis vaccine in more than 70 countries in Southeast Asia and…
Read More...

Hyderabad: Bharat Biotech has sought the approval of the Drug Controller General of India (DCGI) to conduct Phase 3 trials of its Covid-19 intranasal vaccine, sources said on Monday. The Hyderabad-based vaccine maker has submitted the…
Read More...

Hyderabad: An opened vial of Covid-19 vaccine Covaxin can be stored at 2 to 8 degrees Celsius for up to 28 days and is not required to be discarded immediately in a day or at the end of immunisation session, Bharat Biotech said on Monday.…
Read More...

Hyderabad: Bharat Biotech on Monday announced that it has commenced export of Covid-19 vaccine Covaxin. Long Pending export orders have been executed during November, to be further expanded during the following months, the…
Read More...

Bengaluru: Bharat Biotech Director, V. Krishna Mohan, has said developing the Covaxin in "just 10 months" was an enormous challenge. Addressing a session on Thursday at the Bengaluru Tech Summit-2021, he said there were no vaccines when…
Read More...

Hyderabad: Covaxin, India's first indigenous vaccine for Covid-19, has been found to be 77.8 per cent effective, according to the safety and efficacy analysis data from Phase III clinical trials peer reviewed and published in reputed…
Read More...

New Delhi: Hyderabad-based pharma major Bharat Biotech's Covid vaccine Covaxin will be added to the UK government's approved list of vaccines for international travellers from November 22. "From 4 a.m. on Monday 22 November, the…
Read More...

New Delhi: Hyderabad-based pharma major Bharat Biotech's US partner Ocugen has sought the Emergency Use Authorisation (EUA) from the US FDA for Covaxin to be administered in children aged two to 18 years. Ocugen said that it has…
Read More...